Skip to main content
VCbacked
Log inGet Started

Cure Rare Disease

Boston, United States

Cure Rare Disease is a biotechnology company.

$7.4M raised
Dec 2025
Grant
BiotechnologyHealth CareNon ProfitWellness

Top Investors

Muscular Dystrophy AssociationCalifornia Institute for Regenerative Medicine

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cure Rare Disease

How much funding has Cure Rare Disease raised?
Cure Rare Disease has raised $7.4M in total funding. The most recent round was Grant. The last funding was announced in December 2025.
Who are Cure Rare Disease's investors?
Cure Rare Disease's investors include Muscular Dystrophy Association, California Institute for Regenerative Medicine.
Where is Cure Rare Disease headquartered?
Cure Rare Disease is headquartered in Boston, United States.
What does Cure Rare Disease do?
Cure Rare Disease is a biotechnology company.
What stage is Cure Rare Disease at?
Cure Rare Disease is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cure Rare Disease — Funding & Investors." VCBacked, December 11, 2025, https://www.vcbacked.co/company/cure-rare-disease. Accessed July 3, 2026.
APA
VCBacked. (2025). Cure Rare Disease — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/cure-rare-disease
Wikipedia (cite web)
{{cite web |title=Cure Rare Disease — Funding & Investors |url=https://www.vcbacked.co/company/cure-rare-disease |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K